medicine-news-1/atherotech-adds-new-cardiometabolic-tests-amid-strong-2009-growth-54331-2/;+health+history;+medical+history.html
| We're sorry, that page (http://www.bio-medicine.org/medicine-news-1/atherotech-adds-new-cardiometabolic-tests-amid-strong-2009-growth-54331-2/;+health+history;+medical+history.html) was not found. Search medicine news 1 atherotech adds new cardiometabolic tests amid strong 2009 growth 54331 2 ;+health+history;+medical+history html at Google Search medicine news 1 atherotech adds new cardiometabolic tests amid strong 2009 growth 54331 2 ;+health+history;+medical+history html at Yahoo Search medicine news 1 atherotech adds new cardiometabolic tests amid strong 2009 growth 54331 2 ;+health+history;+medical+history html at Msn |
Breaking Biology Technology:BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 3CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 2CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 3New antioxidant compounds have been identified in foods such as olive oil, honey and nuts 2Nutek, LLC Introduces New Soy-Based, Biodegradable Lubricating and Cleaning Wipes 2
[0] BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes[0] CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner [0] New antioxidant compounds have been identified in foods such as olive oil, honey and nuts[0] Nutek, LLC Introduces New Soy-Based, Biodegradable Lubricating and Cleaning Wipes
Breaking Medicine Technology:Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Press conference schedule announced for TCT 2009 55559 1Press conference schedule announced for TCT 2009 55559 2Unique study isolates DNA from Linnaeus botanical collections 9719 1Phoenix Cardiovascular Surgeon David J Caparrelli M D Becomes Member of the Society for Vascular Surgery 55552 1Phoenix Cardiovascular Surgeon David J Caparrelli M D Becomes Member of the Society for Vascular Surgery 55552 2Phoenix Cardiovascular Surgeon David J Caparrelli M D Becomes Member of the Society for Vascular Surgery 55552 3
[0] Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock[0] Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase[0] ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
| Copyright © 2003-2007 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |